Stock profile

DongBang Medical(240550.KQ)

Country: South KoreaSector: HealthcareIndustry: Medical - DevicesExchange: KOE
P/E TTM
N/A
History
P/E NTM
N/A
Market cap
127.75B
Currency KRW
KvantraRankiN/ANot enough data to calculate KvantraRank
ValueN/A
QualityN/A
MomentumN/A
Current price
6,690.00+0.15%
Benchmarks

No price history available.

Key financial summary

Financials in KRW
202020212022202320242025TTM2026E
Total revenueKRWmN/AN/AN/AN/AN/AN/AN/AN/A
Operating profitKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net profitKRWmN/AN/AN/AN/AN/AN/AN/AN/A
EPS reportedKRWLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flowKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net debtKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value equityKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)KRWLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in KRW
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

DongBang Medical Co., Ltd., established in 1985 and headquartered in Seongnam-si, South Korea, is a prominent manufacturer and distributor specializing in a wide array of medical devices, bio medical solutions, cosmetic devices, and aesthetic fillers. The company's product portfolio includes hyaluronic acid (HA) fillers, marketed under brand names such as ELASTY GRAND, ELASTY DEEP PLUS, and ELASTY G PLUS, which are utilized for facial wrinkle improvement and volume restoration. They also offer various aesthetic threads, including ELASTY LINE, ELASTY MESHFILL, and ELASTY-V BARB, alongside essential medical consumables like cannulas, needles, and syringes. Beyond medical aesthetics, DongBang Medical provides an extensive range of skincare and haircare products. This includes moisturizing masks (Hyaluronic acid, Beta-Glucan), the FILL US patch, and specialized lines such as AG Solution (calming, defying, regenerating), AT Solution (cleansing, moisturizing, concentrated), AC Solution (clarifying, refining), and Hair Solution (shampoo, treatment, tonic), complemented by HA ESSENCE. Furthermore, their offerings extend to traditional healthcare items like hand acupuncture devices (e.g., hand acupuncture, spring hand acupuncture tube) and various other general goods such as pillows, charcoal, heat-resistant silicone, and cupping tools. DongBang Medical has a significant international presence, exporting its products to approximately 50 countries across North America, South America, Europe, Asia, and the Middle East.

SectorHealthcare
IndustryMedical - Devices
CountrySouth Korea
Trades inKRW

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

DongBang Medical (240550.KQ)

240550.KQ · KOE · Healthcare
6,690.00+0.15%
Sign up to track this stock

No price history available.

KvantraRankN/A
P/E TTMN/A
P/E NTMN/A
Market cap127.75B
KvantraRank

Not enough data to calculate KvantraRank

Financialsin KRW
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

DongBang Medical Co., Ltd., established in 1985 and headquartered in Seongnam-si, South Korea, is a prominent manufacturer and distributor specializing in a wide array of medical devices, bio medical solutions, cosmetic devices, and aesthetic fillers. The company's product portfolio includes hyaluronic acid (HA) fillers, marketed under brand names such as ELASTY GRAND, ELASTY DEEP PLUS, and ELASTY G PLUS, which are utilized for facial wrinkle improvement and volume restoration. They also offer various aesthetic threads, including ELASTY LINE, ELASTY MESHFILL, and ELASTY-V BARB, alongside essential medical consumables like cannulas, needles, and syringes. Beyond medical aesthetics, DongBang Medical provides an extensive range of skincare and haircare products. This includes moisturizing masks (Hyaluronic acid, Beta-Glucan), the FILL US patch, and specialized lines such as AG Solution (calming, defying, regenerating), AT Solution (cleansing, moisturizing, concentrated), AC Solution (clarifying, refining), and Hair Solution (shampoo, treatment, tonic), complemented by HA ESSENCE. Furthermore, their offerings extend to traditional healthcare items like hand acupuncture devices (e.g., hand acupuncture, spring hand acupuncture tube) and various other general goods such as pillows, charcoal, heat-resistant silicone, and cupping tools. DongBang Medical has a significant international presence, exporting its products to approximately 50 countries across North America, South America, Europe, Asia, and the Middle East.

SectorHealthcare
IndustryMedical - Devices
CountrySouth Korea
Trades inKRW

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans